Ubix Therapeutics, Inc.
1 clinical trials · Sponsor
◉ Watch Ubix Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| UBX-303061 in Subjects With Relapsed/Refractory B-Cell Malignancies (NCT06590961) | Ubix Therapeutics, Inc. | 2025-02-20 |
Track Ubix Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.